Hereditary cancer syndromes: If you look, you will find them

Pediatric Blood and Cancer

Volumn 58, Issue 1, 2012, Pages 5-6

  Schiffman, Joshua D ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADRENAL CORTEX CARCINOMA; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVOR; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CHOROID PLEXUS TUMOR; COMPUTER ASSISTED TOMOGRAPHY; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; HUMAN; NEPHROBLASTOMA; NOTE; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RHABDOID TUMOR;

GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY;

EID: 81155149455     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23336     Document Type: Note

References (10)

1. Pakakasama S, Tomlinson GE. Genetic predisposition and screening in pediatric cancer. Pediatr Clin North Am 2002; 49: 1393-1413.
2. Strahm B, Malkin D. Hereditary cancer predisposition in children: Genetic basis and clinical implications. Int J Cancer 2006; 119: 2001-2006.
3. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991; 63: 993-999.
4. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23: 276-292.
5. Scheuner MT, McNeel TS, Freedman AN. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med 2010; 12: 726-735.
6. Nichols KE, Malkin D, Garber JE, et al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001; 10: 83-87.
7. Qualman SJ, Bowen J, Erdman SH. Molecular basis of the brain tumor-polyposis (Turcot) syndrome. Pediatr Dev Pathol 2003; 6: 574-576.
8. Lwiwski N, Greenberg CR, Mhanni AA. Genetic testing of children at risk for adult onset conditions: When is testing indicated? J Genet Couns 2008; 17: 523-525. Epub 2008 Jul 8.
9. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 2003; 21: 2397-2406.
10. Villani A, Tabori U, Schiffman J, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 2011; 12: 559-567.